首頁 > 市場調查報告書 > 醫療設備

病患監測

市場調查報告書

商品編碼

1542898

全球非侵入性血壓計市場 - 2024-2031

Global Non-Invasive Blood Pressure Monitors Market - 2024-2031

出版日期: 2024年08月26日 | 出版商:

DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

報告概述

2023年，全球非侵入性血壓計市場規模達到24.305億美元，預計到2031年將達到53.5315億美元，2024-2031年預測期間複合年成長率為10.71%。

血壓計在醫院中用於測量重症患者或將要進行任何外科手術的患者的血壓。血壓計用於手術室、重症監護室、手術恢復室、急診室和其他重症監護區域定期或連續測量血壓。在患者病情危急期間檢查血壓，因為它在診斷中起著重要作用。

非侵入性血壓計市場動態

全球高血壓和心血管疾病的興起以及政府的控制、老年人口的增加以及非侵入性血壓監測儀的技術進步是預測期內推動市場的因素。

正在進行的非侵入性血壓監測儀研究預計將推動市場成長。

BPro（Healthstats，新加坡）是一款用於動態血壓測量的腕錶式橈動脈血壓計。首先用臂套裝置對其進行校準。手錶在校準後至少 24 小時內提供準確的結果。該裝置包括一個帶有簡單圖形使用者介面的表頭和一個壓在橈動脈上的柱塞。醫療保健專業人員將柱塞粘在手腕上進行校準，以防止使用時移動。該設備已通過 AAMI 和 ESH 標準的驗證，SBP 和 DBP 讀數分別為 (0.9 - 7.6) mmHg 和 (1.1 - 6.1) mmHg。

此外，圖爾庫大學的研究小組在 2020 年提出了一種桌上型血壓儀，即手指動脈非侵入性血壓監測儀 (FANTOM)。張力測量無袖帶機電系統用於向指尖施加壓力並使用示波法測量血壓。該設備可以測量動脈波形和中心血壓（CBP）。將此設備與自動臂帶監測儀進行比較的任意驗證協議產生的 SBP 和 DBP 結果分別為 (0.9 ± 7.3) mmHg 和 (3.3 ± 6.6) mmHg。因此，正在進行的無袖帶無創血壓監測儀的研究預計將在預測期內得到推動。

無創血壓測量的缺點預計將阻礙市場成長。

非侵入性血壓測量在極端壓力下可靠性較差，且無法連續監測；如果設定重複得太頻繁，並且需要手動操作以獲得最大精度（即，自動模式對於不穩定的患者來說不可靠），這可能會很痛苦。因此，綜合上述因素，預計市場在預測期內將受到阻礙。

COVID-19 對非侵入性血壓監測儀市場成長的影響

COVID-19 大流行對非侵入性血壓監測儀市場產生了適度影響。專家意識到，當全球範圍內的病毒病例開始上升時，COVID-19 對患有心臟病和相關疾病的人尤其危險，尤其是患有高血壓的人。美國一億三百萬成年人（即近一半成年人）患有高血壓，也稱為高血壓。更令人擔憂的是，只有四分之一的成年人的血壓得到控制。血壓不受控制會導致心臟病和中風等嚴重併發症。隨著 COVID-19 疫情的持續爆發，一個新問題出現了。高血壓患者可能容易受到更致命和更嚴重的冠狀病毒副作用的影響。因此，現在對非侵入性血壓計的需求越來越大。

此外，COVID-19 還有另一個潛在的有害影響。這導致許多患者避開當地醫院和急診室，因為他們可能會感染冠狀病毒。全國各地的醫院報告緊急醫療需求的就診人數減少。儘管如此，一些專家認為這並不是因為患者經歷的次數減少，而是因為他們推遲或推遲尋求治療。因此，從上述因素來看，市場受到影響，預計在預測期內將有所改善。

非侵入性血壓計市場細分

預計數位細分市場將在非侵入性血壓監測儀中佔據最大的市場佔有率

2021 年，數位細分市場佔據最大市場佔有率。它們非常適合在家中使用，特別是在患者測量血壓的情況下。他們採用電子壓力感測器來協助測量血壓。結果，讀數以數字方式顯示在螢幕上。數位血壓計將有助於節省時間。這將使患者無需向幫助您監測血壓的醫生支付不必要的費用。雖然大多數型號都是電池供電，但有些型號專為現場使用而設計，並具有雙電源，包括太陽能和電池。

此外，數位血壓計對於有聽力或視力障礙的人來說是一個絕佳的選擇。有些甚至提供紙本列印輸出來幫助您保存記錄。這有助於您的醫生在下次預約時評估您的健康狀況。因此，增加了對數位非侵入性血壓計的需求。因此，從上述因素來看，該細分市場在預測期內佔據了最大的市場佔有率。

無創血壓計市場地理佔有率

北美地區在全球無創血壓計市場中佔有最大的市場佔有率

北美地區在2021年佔據最大的市場佔有率。因素預測期內的成長。例如，根據美國疾病管制與預防中心的數據，高血壓會增加心臟病和中風的風險，而心臟病和中風是美國的主要原因。 2020 年，高血壓是美國超過 67 萬人死亡的主要原因。不受控制的高血壓影響約一半的成年人 (45%)，其血壓為 140/90 mmHg 或更高。其中包括美國 3700 萬成年人。

此外，2022年8月31日，Sensifree LTD獲得了SentiCor-100符合新歐盟MDR的CE證書。 SentiCor-100 是世界上第一款獲准在醫院使用的基於 PPG 的連續非侵入性血壓 (cNIBP) 監測設備。因此，從上述因素來看，北美地區在預測期內佔據了最大的市場佔有率。

非侵入性血壓計公司

非侵入性血壓監測器市場的主要參與者包括 GE Healthcare、SOMNOmedics、Eccosur SA、Koninklijke Philips NV、Huntleigh Technology Ltd.、Mortara Instrument、Schiller Americans Inc.、American Diagnostic Corporation 和 Welch Allyn。

通用電氣醫療保健：

概述：

GE醫療集團是美國跨國集團通用電氣公司的子公司。截至 2017 年，該公司生產和分銷用於醫學成像程序中使用的成像模式的診斷成像劑和放射性藥物。 GE Healthcare 也生產醫療診斷設備，包括 CT 影像機。此外，它還開發用於醫學影像和資訊技術、醫療診斷、病患監測系統、疾病研究、藥物發現和生物製藥製造的健康技術。該公司業務遍及 100 多個國家。

產品組合：

CRITIKON SOFT-CUF 血壓袖帶：CRITIKON SOFT-CUF 由柔軟、吸收性材料製成，具有圓角，可最大限度地提高患者在長期住院期間的舒適度。這些袖帶非常適合長期住院的患者或袖帶在患者整個住院期間隨身攜帶的方案。它可以清洗並重複用於多個患者。儘管如此，它的價格仍然合理，因此可以在單一患者使用後丟棄，以更經濟的方式預防感染。

全球無創血壓監測儀市場報告將提供約。 45+市場資料表，40+圖表，180頁。

Blood pressure monitors are used in hospitals to measure the blood pressure of patients who are critically ill or will be operated on for any surgical procedure. Blood pressure monitors are used in the operating room, intensive care units, surgical recovery rooms, emergency departments, and other critical care areas to measure blood pressure regularly or continuously. Blood pressure is checked during a patient's critical condition because it plays an important role in diagnosis.

Non-Invasive Blood Pressure Monitors Market Dynamics

The global rise of hypertension and cardiovascular diseases and governmental control, the rising geriatric population, and technological advancement in non-invasive blood pressure monitors are the factors to drive the market in the forecast period.

Ongoing research for non-invasive blood pressure monitors is expected to drive market growth.

BPro (Healthstats, Singapore) is a wristwatch radial artery tonometer for ambulatory blood pressure measurement. It is calibrated with a brachial cuff device at first. The watch provides accurate results for at least 24 hours after calibration. The device comprises a watch head with a simple graphic user interface and a plunger to be pressed against the radial artery. The plunger is taped to the wrist by the healthcare professional performing the calibration to prevent it from moving while in use. The device has been validated by the AAMI and ESH standards, with SBP and DBP readings of (0.9 7.6) mmHg and (1.1 6.1) mmHg, respectively.

Furthermore, in 2020, a research group at the University of Turku proposed a tabletop form factor blood pressure instrument, the finger artery non-invasive tonooscillometric monitor (FANTOM). A tonometric cuffless mechatronic system is used to apply pressure to the fingertip and measure blood pressure using an oscillometric method. The device can measure arterial waveforms and central blood pressure (CBP). An arbitrary validation protocol comparing the device to an automated arm cuff monitor produced SBP and DBP results of (0.9 7.3) mmHg and (3.3 6.6) mmHg, respectively. Therefore, the ongoing research for cuffless non-invasive blood pressure monitors is expected to drive in the forecast period.

Drawbacks of non-invasive blood pressure measurements are expected to hamper market growth.

Non-invasive blood pressure measurement is less reliable at pressure extremes, and continuous monitoring is impossible; it can be painful if set to repeat too frequently and requires manual operation for maximum accuracy (i.e., automatic modes are unreliable in unstable patients). Thus, from the above factors, the market is expected to be hampered in the forecast period.

COVID-19 Impact on Non-Invasive Blood Pressure Monitors Market Growth

The COVID-19 pandemic has impacted the non-invasive blood pressure monitors market moderately. Experts realized that COVID-19 was especially dangerous for people with heart disease and related conditions, especially high blood pressure when cases of the virus started to rise globally. One hundred three million adults in the United States, or nearly half of all adults, have high blood pressure, also referred to as hypertension. Even more concerning is the fact that only 1 in 4 adults have their blood pressure under control. Uncontrolled blood pressure can result in severe complications like heart attack and stroke. As COVID-19 outbreaks persisted, a new issue surfaced. High blood pressure sufferers may be susceptible to more fatal and severe coronavirus side effects. As a result, there is now more of a demand for non-invasive blood pressure monitors.

In addition, COVID-19 has another potentially harmful effect. It has caused many patients to avoid local hospitals and emergency rooms because they might contract the coronavirus. Hospitals nationwide are reporting a decrease in visits for urgent medical needs. Still, some experts think this isn't because patients are experiencing fewer of them rather than because they are putting off or postponing seeking treatment. Thus, from the above factors, the market got affected and is expected to improve in the forecast period.

Non-Invasive Blood Pressure Monitors Market Segmentation

The digital segment is expected to hold the largest market share in non-invasive blood pressure monitors

The digital segment accounted for the largest market share in 2021. The convenience that a digital blood pressure monitor provides in its mode of operation. They are ideal for use at home, particularly if the patient takes blood pressure readings. They employ electronic pressure sensors to assist in the measurement of blood pressure. As a result, readings are displayed digitally on a screen. A digital blood pressure monitor will help save time. It will save the patient from paying unnecessary fees to doctors who help you monitor their blood pressure. While most are battery-powered, some models are designed for field use and have dual power sources, including solar and battery cells.

Furthermore, digital blood pressure monitors are an excellent choice for people who have hearing or vision impairments. Some even provide paper printouts to assist you in keeping records. This helps your doctor evaluate your health at your next appointment. Therefore, it has increased the demand for digital non-invasive blood pressure monitors. Thus, from the above factors, the market segment accounted for the largest market share in the forecast period.

Non-Invasive Blood Pressure Monitors Market Geographical Share

North America region holds the largest market share in the global non-invasive blood pressure monitors market

North America region accounted for the largest market share in 2021. The rising geriatric population, rising incidence of hypertension, increasing prevalence of cardiovascular disease, technological advancement in non-invasive blood pressure monitors, and product launches by the market players are the factors driving market growth in the forecast period. For instance, according to the Centers for Disease Control and Prevention, Hypertension increases the risk of heart disease and stroke, which are the leading causes of death in the United States. Hypertension was a primary or contributing cause of more than 670,000 deaths in the United States in 2020. Only about one in every four adults (24%) has hypertension under control. Uncontrolled hypertension affects roughly half of all adults (45%), with a blood pressure of 140/90 mmHg or higher. This includes 37 million adults in the United States.

Furthermore, On August 31, 2022, Sensifree LTD received a CE certificate for SentiCor-100 in compliance with the new EU MDR. SentiCor-100 is the world's first PPG-based Continuous Non-Invasive Blood Pressure (cNIBP) monitoring device approved for hospital use. Thus, from the above factors, the North American region accounted for the largest market share in the forecast period.

Non-Invasive Blood Pressure Monitors Companies

Major key players in the non-invasive blood pressure monitors market are GE Healthcare, SOMNOmedics, Eccosur SA, Koninklijke Philips N.V., Huntleigh Technology Ltd., Mortara Instrument, Schiller Americans Inc., American Diagnostic Corporation, and Welch Allyn.

GE Healthcare:

Overview:

GE Healthcare is a subsidiary of the American multinational conglomerate General Electric Company. The company manufactures and distributes diagnostic imaging agents and radiopharmaceuticals for imaging modalities used in medical imaging procedures as of 2017. Dyes for magnetic-resonance imaging methods are available from the firm. GE Healthcare also manufactures medical diagnostic equipment, including CT image machines. Moreover, it develops Health technology for medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery, and biopharmaceutical manufacturing. The company is operated in more than 100 countries.

Product Portfolio:

CRITIKON SOFT-CUF Blood Pressure Cuffs: CRITIKON SOFT-CUF is made of soft, absorbent material with rounded corners to maximize patient comfort during long hospital stays. These cuffs are ideal for patients with longer-term stays or protocols in which the cuff travels with the patient throughout their stay. It can be cleaned and reused on multiple patients. Still, it is reasonably priced so that it can be discarded after single-patient use, allowing for preventing infections more affordably.

The global non-invasive blood pressure Monitors market report would provide access to approx. 45+market data table, 40+figures and 180pages.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

4.1. Market Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Ongoing research for non-invasive blood pressure monitors is expected to drive market growth.
- 4.1.2. Restraints:
  - 4.1.2.1. Drawbacks of non-invasive blood pressure measurements are expected to hamper market growth.
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Forces
5.2. Supply Chain
5.3. Pricing Analysis

6. COVID-19 Analysis

6.1. Analysis of Covid-19 on the Market
- 6.1.1. Before COVID-19 Market Scenario
- 6.1.2. Present COVID-19 Market Scenario
- 6.1.3. After COVID-19 or a Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Device Type

7.1. Introduction
- 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
- 7.1.2. Market Attractiveness Index, By Device Type
7.2. Automated BP Monitors*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Ambulatory BP Monitors
7.4. Sphygmomanometers
7.5. BP Transducers

8. By Technology

8.1. Introduction
- 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
- 8.1.2. Market Attractiveness Index, By Technology
8.2. Digital*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Aneroid
8.4. Wearable

9. By Accessory

9.1. Introduction
- 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
- 9.1.2. Market Attractiveness Index, By Accessory
9.2. Blood Pressure Cuffs*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Manometers
9.4. Valves and Tubing
9.5. Bulbs

10. By End-user

10.1. Introduction
- 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
- 10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
10.3. Clinics
10.4. Ambulatory Surgical Center
10.5. Home Care Setting
10.6. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
- 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
- 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
- 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
- 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. The U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
- 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
- 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
- 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
- 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. The U.K.
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Spain
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
- 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
- 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
- 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
- 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
- 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
- 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
- 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
- 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
- 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
- 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
- 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. GE Healthcare*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Key Highlights
- 13.1.4. Financial Overview
13.2. SOMNOmedics
13.3. Eccosur SA
13.4. Koninklijke Philips N.V.
13.5. Huntleigh Technology Ltd.
13.6. Mortara Instrument
13.7. Schiller Americans Inc.
13.8. American Diagnostic Corporation
13.9. Welch Allyn(*LIST NOT EXHAUSTIVE)